RPS3a Enhances HBx-Mediated NF-κB Signaling in Hepatocellular Carcinoma
Author Information
Author(s): Lim Keo-Heun, Kim Kyun-Hwan, Choi Seong Il, Park Eun-Sook, Park Seung Hwa, Ryu Kisun, Park Yong Kwang, Kwon So Young, Yang Sung-Il, Lee Han Chu, Sung In-Kyung, Seong Baik L.
Primary Institution: Yonsei University, Konkuk University School of Medicine, University of Ulsan College of Medicine
Hypothesis
Does the over-expressed ribosomal protein RPS3a enhance HBx-induced NF-κB signaling in hepatocellular carcinoma?
Conclusion
RPS3a enhances HBx-induced NF-κB signaling through its chaperoning function, contributing to HBV-related oncogenesis.
Supporting Evidence
- RPS3a was found to be over-expressed in 70% of HBV-positive HCC tissues compared to non-tumor regions.
- RPS3a enhances the solubility of HBx, preventing its aggregation.
- Knock-down of RPS3a abolished the enhancement of NF-κB signaling by HBx.
Takeaway
RPS3a is a protein that helps another protein, HBx, work better in causing liver cancer. It does this by keeping HBx from clumping together.
Methodology
The study involved co-transfection of ribosomal proteins with HBx in liver cell lines and analysis of NF-κB activity using luciferase assays.
Potential Biases
Potential bias in sample selection and the reliance on specific cell lines may affect the generalizability of the findings.
Limitations
The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.
Participant Demographics
The study analyzed tissues from 20 HBV-positive hepatocellular carcinoma patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website